Our ambition is to change lives by changing the course of blood cancer.

Powered by pioneering science

Investor Event

Earnings.

Geron to announce third quarter 2024 financial results and business highlights on November 7 ›

Research & Development

Two people engaged in discussion at a conference table.

Developing innovative medicines for myeloid hematologic malignancies >

Patients

woman in glasses smiling

We are on a mission to extend and enhance patients’ lives ›

Culture

A man with gray hair wearing a dark blue blazer and light blue shirt looks off to the side with a thoughtful expression.

We see things in ways others do not ›

Careers

Join us and become a part of something special